Julie Mauskop on David Zwirner’s Platform

September 11, 2021


Patients coming to the New York Headache Center have enjoyed seeing my daughter Julie’s artwork since she was 11. This was not just a childhood interest – Julie graduated from the Rhode Island School of Design with a degree in painting. She has continued to work hard as a painter and her perseverance and talent have led to wider recognition.

Julie is represented by a New York City gallery, SHRINE. A few days ago, her work was selected for Platform, a new online initiative by David Zwirner.

You can see more of Julie’s work on her Instagram page.

Written by
Alexander Mauskop, MD
Continue reading
August 8, 2026
Sugar is bad for your brain, even before you are born.
Sugar consumed in the first two years of life increases the risk of dementia.
Read article
August 6, 2026
Research
An Old Medicine that Could Make Brain Stimulation Work Better for Depression and Other Neurological Conditions
A 2022 clinical trial from the University of Calgary found that adding low‑dose D‑cycloserine (DCS), a partial NMDA‑receptor agonist, to intermittent theta‑burst stimulation (iTBS) significantly increased response and remission rates in depression without serious side effects. Early follow‑up data suggest that timing, dose, and drug levels matter, and raise the possibility that this DCS‑TMS approach could eventually be applied to other neurological conditions—such as migraine, postconcussion syndrome, brain fog, and long COVID
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe